Picture of Twist Bioscience logo

TWST — Twist Bioscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Twist Bioscience Reports Fiscal First Quarter 2023 Results

Feb 3 (Reuters) - Twist Bioscience Corp  TWST.O :
    * TWIST BIOSCIENCE REPORTS FISCAL FIRST QUARTER 2023
FINANCIAL
RESULTS
    * Q1 EARNINGS PER SHARE VIEW $-1.13, REVENUE VIEW $54.1
MILLION --
REFINITIV IBES DATA
    * Q1 LOSS PER SHARE $0.74
    * FULL FISCAL YEAR 2024 REVENUE IS EXPECTED TO BE
APPROXIMATELY
$350 MILLION
    * FULL FISCAL YEAR 2024 CAPITAL EXPENDITURE IS EXPECTED TO
BE
APPROXIMATELY $40 MILLION
    * FY2024 REVENUE VIEW $346.5 MILLION -- REFINITIV IBES DATA
    * SAYS FY 2023 REVENUE GUIDANCE UNCHANGED FROM NOVEMBER 2022
GUIDANCE AND EXPECTED TO BE IN RANGE OF $261 MILLION TO $269
MILLION
    * Q1 REVENUE $54.2 MILLION

Source text for Eikon:  ID:nBw2cP1RWa 
Further company coverage:  TWST.O 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Twist Bioscience

See all news